Skip to content

Public FDA record

Z-1405-2014: Fentanyl Test Card; LumiQuick,. Santa Clara, CA 95054

Recall record Z-1405-2014 for LumiQuick Diagnostics Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1405-2014
Company in FDA record
LumiQuick Diagnostics Inc.
FDA classification date
Apr 7, 2014
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Products shipped to US locations that do not have approved applications for PMA , IDE or 510(k) clearance.

Source facts

Action
Urgent Device Recall notification letters were sent to all US consignees on March 4, 2014 by e-mail and US mail as well as a phone call. The letter identified the products and actions to be taken by the customers.
Initiated
2014-03-04
Root cause
No Marketing Application
Terminated
2014-05-09
Distribution
Distributed in the states of CA, FL, NJ, TX, and NY.
Recall number
Z-1405-2014
Recall status
Terminated
CDRH record ID
126044
FDA classified
2014-04-07
Recall event number
67665

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗